Ex-Regulator Said to Testify GlaxoSmithKline Withheld Study

A former U.S. Food and Drug Administration official said GlaxoSmithKline Plc withheld from regulators a study showing its Avandia diabetes drug may cause heart attacks, according to two people familiar with her deposition in a lawsuit against the drugmaker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.